What's new

Human medicines European public assessment report (EPAR): Obgemsa, vibegron, Date of authorisation: 27/06/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Obgemsa, vibegron, Date of authorisation: 27/06/2024, Revision: 1, Status: Authorised

Feb 19, 2025 - 16:04
 0
Human medicines European public assessment report (EPAR): Obgemsa, vibegron, Date of authorisation: 27/06/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Obgemsa, vibegron, Date of authorisation: 27/06/2024, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Ford To Push Back the Launch of Its Next-Generation F-150 Pickup

Next Article

American Circular Textiles applauds the Senate EPW Committee for advancing key r...

Related Posts

EMEA-002565-PIP02-19-M01

EMEA-002565-PIP02-19-M01

Apr 2, 2025  0

Human medicines European public assessment report (EPAR): Nimvastid, rivastigmine, Date of authorisation: 11/05/2009, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 26, 2025  0

Human medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Date of authorisation: 31/05/2022, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 13, 2025  0